Dxcover
developer of a blood test that can detect cancer
Dxcover has raised €11M across 2 funding rounds from 11 investors, most recently a round in Feb 2025. Based in Glasgow, UK; active in Healthtech. Data as of 28 Oct 2026.
Glasgow, UKwww.dxcover.com ↗
Total raised
€11M
€10,971,237
Funding rounds
2
Investors
11
distinct backers
Active since
2023-02
latest 2025-02
Funding by year
EUR raised per yearDxcover — funding by year — interactive chart.
Data table
| Dxcover — funding by year | |
|---|---|
| 2023 | €11M |
| 2025 | €0 |
Signals
Medium confidenceRaise-next likelihood35
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-03 | Other | — | Existing investors,Macmillan Cancer Support,Maven Capital Partners | View deal → |
| 2023-02-01 | Series A | €11M | Eos Advisory,European Innovation Council (EIC),Mark Bamforth,Mercia Asset Management,Norcliffe Capital,Scottish Enterprise+2 more | View deal → |
Investors
11Related news
- Dxcover Raises £9.7M in Series A Fundingfinsmes.com · 2023-02
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData